|
Diagnosis
|
Case
|
Sex
|
Age (years)
|
PMD (hours)
|
Disease score
|
Reported concomitant misfolded protein pathologies*
|
|---|
|
CTL
|
| |
1
|
F
|
86
|
5.7
|
/
|
/
|
| |
2
|
F
|
80
|
17.5
|
/
|
/
|
| |
3
|
F
|
89
|
23.6
|
/
|
Some senile plaques and NFTs
|
| |
4
|
M
|
89
|
32.2
|
/
|
/
|
| |
5
|
M
|
80
|
13.0
|
/
|
Some senile plaques
|
| |
6
|
F
|
83
|
35.7
|
/
|
/
|
| |
7
|
F
|
95
|
23.7
|
/
|
/
|
| |
8
|
M
|
85
|
26.7
|
/
|
/
|
| |
9
|
M
|
83
|
16.8
|
/
|
/
|
| |
10
|
M
|
89
|
31.9
|
/
|
A1B1C1
|
| |
11
|
F
|
55
|
21.1
|
/
|
/
|
|
DLB
| |
| |
12
|
M
|
70
|
24.5
|
Neo-cortical diffuse
|
Senile plaques and NFTs
|
| |
13
|
M
|
89
|
17.0
|
Limbic transitional
|
Mixed AD
|
| |
14
|
M
|
75
|
21.0
|
Neo-cortical
|
Senile plaques and NFTs
|
| |
15
|
M
|
64
|
17.2
|
Neo-cortical
|
Senile plaques and NFTs
|
| |
16
|
F
|
83
|
17.7
|
Neo-cortical
|
Senile plaques and NFTs
|
| |
17
|
M
|
82
|
22.0
|
Neo-cortical diffuse
|
/
|
| |
18
|
F
|
81
|
8.6
|
Neo-cortical diffuse
|
/
|
| |
19
|
F
|
74
|
27.6
|
Neo-cortical
|
A2B2C0
|
| |
20
|
M
|
91
|
85.0
|
Neo-cortical diffuse
|
Braak III/IV
|
|
AD
| |
| |
21
|
M
|
80
|
15.5
|
Braak IV
|
/
|
| |
22
|
M
|
82
|
11.5
|
Braak IV
|
/
|
| |
23
|
M
|
85
|
31.1
|
A2B3C2
|
/
|
| |
24
|
F
|
83
|
25.0
|
A2B3C2
|
/
|
| |
25
|
M
|
91
|
25.0
|
A2B3C2
|
/
|
| |
26
|
F
|
96
|
26.5
|
Braak IV/V
|
/
|
| |
27
|
M
|
87
|
21.7
|
A2B3C2
|
/
|
| |
28
|
M
|
90
|
26.1
|
A3B2C3
|
/
|
| |
29
|
F
|
87
|
17.0
|
A1B2C2
|
/
|
| |
30
|
M
|
90
|
32.0
|
A2B2C3
|
/
|
- AD Alzheimer’s disease, CTLs age-matched controls, DLB Dementia with Lewy Bodies, NFTs neurofibrillary tangles, PMD post-mortem delay
- *After neuropathological examination
